Dermatology Research and Practice / 2018 / Article / Tab 1

Clinical Study

Effectiveness and Safety of Contrast Cryolipolysis for Subcutaneous-Fat Reduction

Table 1

Mean (SD) for fasting glycemia, serum liver test, and serum lipid values.

Analysis (units)ReferenceTimeP value
Baseline3 weeks later

Glucose (mg/dL)a70-10085.71 ± 9.0484.64 ± 10.990.862

AST (U/L)a10 - 37 ♀ / 11 - 39 ♂18.96 ± 5.8321.27 ± 5.900.169

ALT (U/L)a11 - 45 ♀ / 10 - 37 ♂17.67 ± 11.9621.27 ± 8.710.136

Cholesterol (mg/dL)a< 200176.4 ± 36.35166.1 ± 25.540.491

Triglycerides (mg/dL)b< 200103 ± 63.1689.18 ± 57.420.765

HDL Cholesterol (mg/dL)a> 6550.65 ± 12.0147.09 ± 7.220.348

LDL Cholesterol (mg/dL)a< 130105.2 ± 30.49101.2 ± 26.450.443

VLDL Cholesterol (mg/dL)b< 4020.59 ± 12.6317.84 ± 11.480.765

ALT, alanine aminotransferase; AST, aspartate aminotransferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very-low-density lipoprotein.
aPaired t-test.
bWilcoxon signed-rank test.
A P-value < 0.05 is considered statistically significant.